As of November 2024 Genmab has a market cap of ₹1.101 Trillion. This makes Genmab the world's 1352th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 20th, 2024 the market cap of Genmab was reported to be: